Twinlab Consolidated Holdings Inc
Twinlab Consolidated Holdings, Inc., together with its subsidiaries, manufactures, markets, distributes, and retails nutritional supplements and other natural products in the United States and internationally. The company offers vitamins, minerals, resveratrol, collagen, keratin, specialty supplements, skincare, and sports nutrition products under the Twinlab, Reserveage, and ResVitale brands; he… Read more
Twinlab Consolidated Holdings Inc (TLCC) - Total Liabilities
Latest total liabilities as of September 2025: $153.02 Million USD
Based on the latest financial reports, Twinlab Consolidated Holdings Inc (TLCC) has total liabilities worth $153.02 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Twinlab Consolidated Holdings Inc - Total Liabilities Trend (2012–2023)
This chart illustrates how Twinlab Consolidated Holdings Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Twinlab Consolidated Holdings Inc Competitors by Total Liabilities
The table below lists competitors of Twinlab Consolidated Holdings Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Murchison Minerals Ltd
PINK:MURMF
|
USA | $252.08K |
|
Smartset Services Inc
V:SMAR-P
|
Canada | CA$765.00 |
|
Allspring Multi Sector Income Fund
NYSE MKT:ERC
|
USA | $126.61 Million |
|
AusQuest Limited
OTCGREY:AUQSF
|
USA | $686.40K |
|
KURARAY CO LTD - Dusseldorf Stock Exchang
DU:KUY
|
Germany | €507.79 Billion |
|
Advanced Oxygen Technologies Inc
PINK:AOXY
|
USA | $254.14K |
Liability Composition Analysis (2012–2023)
This chart breaks down Twinlab Consolidated Holdings Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.03 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.05 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 19.94 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Twinlab Consolidated Holdings Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Twinlab Consolidated Holdings Inc (2012–2023)
The table below shows the annual total liabilities of Twinlab Consolidated Holdings Inc from 2012 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | $148.02 Million | +1.23% |
| 2022-12-31 | $146.22 Million | +3.01% |
| 2021-12-31 | $141.96 Million | +3.54% |
| 2020-12-31 | $137.10 Million | +16.04% |
| 2019-12-31 | $118.15 Million | +2.62% |
| 2018-12-31 | $115.13 Million | +14.77% |
| 2017-12-31 | $100.31 Million | +10.16% |
| 2016-12-31 | $91.06 Million | +5.31% |
| 2015-12-31 | $86.47 Million | +95.88% |
| 2014-12-31 | $44.15 Million | -60.97% |
| 2013-12-31 | $113.11 Million | -6.55% |
| 2012-12-31 | $121.04 Million | -- |